Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

25 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Isoflurane Articles

India's Piramal buys Minrade in $40M deal

15 January 2009

Adeka debuts new anesthetic, other Minrad prods

23 June 2008

Minrad completes sevoflurane API line validation

17 December 2007

Baxter launches sevoflurane in China

19 December 2005

Abbott Labs UK receives special award for innovation

24 February 2003

Medeva Takes On Single Isomer Methylphenidate

27 January 1997

Medeva "Not For Sale" But Is On Track For Growth

24 July 1995

BOC Sues Medeva Over Inhalon" Trade Secrets"

10 April 1995

Medeva's 1994 Results Crown Five Years Of Growth

27 March 1995

Filing For Supplement To Albuterol ANDA

20 March 1995

Medeva Acquisition Of Inhalon On Right Track

23 January 1995

New Acquisition For Medeva In The USA

12 December 1994

Pharmacia's Desflurane: Euro Roll-Out In 1995?

5 December 1994

ABBOTT'S HYTRIN GETS BPH APPROVAL IN USA

11 October 1993

ANAQUEST'S SUPRANE LAUNCHED IN USA

2 November 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS